A B S T R A C T Rat small intestinal mucosa was examined for ability to produce mucins with human blood group A, B, and H activity. Blood group activity of the mucins was compared to antigenic activity of red blood cells in individual rats and the enzymatic basis for differences was investigated. Red cells in all the rats examined contained human blood group A and B antigens. All rats synthesized intestinal mucins having B and H antigenic activity but 57% failed to produce mucins with blood group A activity (A-); the remaining 43% (A') produced A substance.
INTRODUCTION
In 1953, Aird and Benthall (1) noted the increased prevalence of gastric carcinoma in blood group A individuals. Since then the connection of blood group status and factors within the gastrointestinal tract has aroused much interest, thought research along these lines has produced little understanding of the mechanisms which might underlies such an association (2) (3) (4) (5) . Substances having ABO blood group activity have been described in various human tissues and secretions (6) (7) (8) (9) (10) (11) . Mainly on the basis of detailed chemical studies on water soluble ABH substances isolated from ovarian cyst fluid, these antigens have been shown to be macromolecular glycoproteins, each consisting of a polypeptide core with multiple oligosaccharide side chains (12) (13) (14) . These oligosaccharide side chains, consisting of several sugars such as L-fucose, D-galactose, N-acetyl-D-glucosamine, and N-acetyl-D-galactosamine, are linked to the polypeptide core primarily through O-glycosidic linkages between the hydroxy groups of serine or threonine and N-acetyl-D-galactosamine. The serological specificities of A or B blood group substances are generally thought to be deter-mined by the presence of terminal N-acetyl-D-galactosamine (A) or D-galactose (B) moieties attached to the H determinant (15) (16) (17) .
It has been observed that mucus secreted by cells such as those in the submaxillary gland, stomach, and colon of various mammalian species, e.g. rat, pig, monkey (18) (19) (20) (21) , and dog,1 has antigenic properties to that associated with human ABO blood group activity.
Differences have been observed in the ability of gastric mucosa of A' or A-pigs to incorporate N-acetylhexosamine, based on the antigenicity of their mucosal 1Kim, Y. S., and A. M. Bella, Jr. Unpublished observations.
extract (19) . Carlson, Iyer, and Mayo (20) and McGuire (21) while studying porcine submaxillary mucins, showed that an enzyme absent in the A-pig could catalyze the transformation of A-submaxillary mucin to a mucin having A' activity. In addition, a number of glycosyltransferases required for the synthesis of mucin were shown to be localized in the microsomal fraction, obtained from the same pooled material (22) .
It has been demonstrated in humans that antigenic determinants on red blood cells, may (secretor) or may not (nonsecretor) appear as secreted glycoproteins in glandular tissues in a form determined by the blood group of the individual (23) .
The purpose of the present study in rats was to answer the following questions. Do all rats synthesize and secrete intestinal mucins having A, B, and H blood group activity in every case? If there are differences among rats in this regard, can the blood group activity of the mucin be correlated with the presence or absence of these antigens on the red blood cells of individual rats? Lastly, what are the biological mechanisms responsible for differences between the blood group activity of the red blood cells and the secreted mucins ? METHODS Preparation of microsomes and mucins. Sprague-Dawley albino male rats weighing 150-200 g were allowed to eat purina chow diet and to drink water ad lib. until they were killed by decapitation. All subsequent procedures were carried out at 4VC. The entire length of the small intestine was removed immediately, flushed with ice-cold 0.9% NaCl solution, everted, and the mucosa scraped. A portion of the mucosal scrapings was used to prepare the aqueous extracts for testing for the presence of human ABH blood grouplike substances as follows. About 500 mg (wet weight) of the mucosal scrapings were homogenized in 2 volumes of 0.9% NaCl (v/w) in a Potter-Elvehjem tissuehomogenizer, and centrifuged at 20,000 g for 10 min. The supernate was tested for hemagglutination-inhibition.
The remaining material was used to prepare microsomes to be used either as a source of glycosyltransferases or as an exogenous acceptor for these enzymes. The scrapings were homogenized in 4 volumes (v/w) of 0.25 M sucrose in a Potter-Elvehjem homogenizer. The mucosal homogenate was then processed by the use of the differential centrifugation method to obtain the microsomal pellet (22) . The microsomal pellets were resuspended in 0.25 M sucrose (5 mm in MgC12, 20 mm in Tris-maleate, pH 7.4, and 25 mM in KCl), adjusted to a final concentration of 0.5% in Triton X-100, rehomogenized and allowed to stand for 1 hr. The suspension was sonicated extensively, dialyzed against distilled water, lyophilized, and stored at -20'C until used.
Mucins were prepared as described previously (24) . Preparation of glycosyltransferase acceptors. A microsomal acceptor was prepared by heat treatment as described previously (22) . The ,umoles of cacodylate acetate buffer, pH 6 .0.
Preparation of rabbit anti-human blood group A antisera. For use both in the immunoprecipitin analysis and the immunodiffusion studies, rabbit antiserum against human A blood group substance was prepared as follows: red cell stroma free of hemoglobin (2 mg protein) prepared by the method of Dodge, Mitchell, and Hanahan (33) were injected weekly in the foot pads of New Zealand rabbits with complete Freund's adjuvant. On the 8th wk, a booster of 5 mg of red cell stromal protein prepared in 0.02 M Tris-HCl, pH 7.5, was injected intravenously and a week later blood was obtained by cardiac puncture from the overnight fasted rabbits. Merthiolate was added immediately to the serum (1: 10,000). 5 ml each of serum was then absorbed with 20 mg dry weight of human type 0 stroma twice by incubating the mixture first at 25°C for 2 hr and then at 4°C for 48 hr. The mixture was centri-fuged at 40,000 g for 30 min and the resultant anti-A serum was stored at -20'C until used.
Conversion of A-to Al mucin. A-mucin (30 ,ug) was incubated with A+ microsomes (1 mg protein) under the condition described for the N-acetylgalactosaminyltransferase. The incubation was for 5 hr at 370C and UDP-Nacetyl-D-galactosamine-1-"4C of low specific activity (1 X 106 dpm//hmole) was used as a substrate in the final concentration of 1 mm. UDP-N-acetyl-D-galactosamine-1-14C of low specific radioactivity was prepared according to the method of Carlson, Swanson, and Roseman (34) . The incubation mixture was centrifuged at 35,000 g for 30 min before samples were taken for immunochemical analysis and radioactivity measurement. Radioactivity incorporated into macromolecules was determined by precipitation with phosphotungstic acid as described for the enzyme assay.
Immunoprecipitin analysis. Portions (50 1ul) were taken from the above incubation mixture and transferred to a series of conical centrifuge tubes (1 ml) containing various amounts of rabbit A antisera. The immunoprecipitin reaction was carried out in a final volume of 0.3 ml by adding 0.9% NaCl containing 0.02% sodium azide at 250C for 2 hr and 38 hr at 4VC with twice daily gentle mixing. The precipitates were obtained by centrifuging the reaction mixtures at 2,000 g for 15 min, and washed with ice-cold 0.9% saline until no radioactivity was extracted by the wash. The precipitates were resuspended in 1 ml of distilled water and their radioactivity counted in a scintillation spectrometer after an addition of 10 ml of Insta-gel (Packard Instrument Co., Inc., Downers Grove, Ill. Mucins prepared from A and A-rats were tested at two concentrations. (1 and 2.5 mg/ml) against the rabbit antisera. Saliva and saline extracts of intestinal mucosa from human blood type A secretors were heated at 80°C for 10 min. The coagulates were removed by centrifugation and the supernatant fluids were dialyzed, concentrated, and applied to the immunoplates at 6 mg per ml. Absorption of rabbit anti-human A sera by A+ PSM and salivary mucin from a human blood group A secretor was performed as follows: 0.1 ml portions of antisera were mixed with 300 ,ug of either A+ PSM or human salivary mucin, incubated first at 25°C for 2 hr and then at 4°C for 24 hr. Tubes were centrifuged and the supernatant fluid applied to double immunodiffusion plates. A control of antisera plus saline was incubated and handled in the same fashion. The immunodiffusion plates were developed at room temperature for 4 days, rinsed in saline for 3 days. with two changes per day. Staining of plates was done with 0.5% amido black in 7% acetic acid for 15 min at 25°C; destaining was performed with 7% acetic acid until background was clear.
Hemagglutination inhibition test. Human blood group activity in the aqueous extract of rat small intestinal mucosa was determined by the method of Bendich, Kabat, and Bezer (36). The supernatant fluid (100 /d) obtained by centrifuging the rat small intestinal homogenate at 20,000 g as described above was preincubated for 30 min at 25°C with 50 ,ul each of human anti A or B typing serum (Hyland Laboratories, Los Angeles, Calif.) at three dilutions of the antiserum above the agglutination limit. To this 50 ,ul of 5% human A or B cell suspension were added and agglutination determined by microscopy. Eel serum (Marine Biological Laboratory, Woods Hole, Mass.) and anti H lectin (Ulex europaeus) were used to determine human blood group 0 (H) activity. The specificity of these H specific hemaglutinins was determined using human group A, B, and 0 red cells. Only group 0 red cells were agglutinated.
Hemagglutination inhibition by converted mucins. Amucin was incubated with A+ microsomal suspensions prepared by sonication in the absence of Triton X-100. The incubation mixtures and conditions were similar to those used for the immunoprecipitin analysis except for the omission of Triton X-100. The incubation mixture was centrifuged and 50 ,ul of the clear supernatant fluid was checked for blood group A activity by the hemagglutination-inhibition test as described above.
RESULTS
Antigenic properties of. rat mucin. Aqueous extracts of rat intestinal mucosa were examined for their ability to inhibit human A-anti A hemagglutination. Of 68 rats thus examined, 29 inhibited hemagglutination and were designated A positive (A+), 39 failed to inhibit and were designated A negative (A-). In contrast, when these extracts were examined for the presence of B blood group activity in a human B-anti B hemagglutination assay, all extracts possessed B activity.
Using both H specific hemagglutinin from eel serum and anti H lectin from Ulex europaeus, all mucosal extracts demonstrated H antigenic activity. Mucins were purified from the aqueous extracts of intestinal mucosa and were examined for their antigenic properties using immunodiffusion techniques. Precipitating antiserum prepared from rabbits was used. Comparison was made between rat intestinal mucins and salivary and small intestinal mucins from a blood group A human secretor (Fig. 2) . Mucins from A+ rats formed a single immunoprecipitin line which fused with both of the human blood group A substances. No immunoprecipitin line was observed with the A-mucins. As shown in Fig. 3 Table I . The D-glucosamine content was identical in the A+ and A-rats but D-galactosamine was 3 times higher in the A+ than in the AMmicrosomes. Glycosyltransferase activity in A+ and A-small intestinal mucosa. Microsomes were prepared from A+ and A-rats and their abilities to catalyze the incorporation of radioactive sugars into heat-treated microsomal acceptors were measured (Table II) . The A+ microsomes were 60 times more effective than the A-micro- polypeptidyl :N-acetylgalactosaminyltransferase catalyzed the addition of this sugar to the protein core (Figs. 1 and 4). Using heat-treated microsomal acceptors, one cannot quantitatively distinguish the activities of these two enzymes.
To distinguish between these two enzymes, therefore, specific protein acceptors of known structure were employed. As shown in Table III , the activity of the polypeptidyl :N-acetylgalactosaminyltransferase using a specific acceptor was the same in both A+ and A-rats. However, a marked difference was noted in the activity of the N-acetylgalactosaminyltransferase. In A+ microsomes, the activity of this enzyme was over 500 times that in A-microsomes. The activities of both galactosyltransferase and fucosyltransferase were similar in both groups, as was observed previously when heat-treated microsomes were used as the acceptor.
The porcine submaxillary mucin used as an acceptor for the N-acetylgalactosaminyltransferase contains an H-like blood group determinant, but may also contain other structures to which N-acetyl-D-galactosamine may be attached. Oligosaccharides of well-defined structure were therefore employed to determine whether the H determinant structure of the acceptor is required for the addition of N-acetyl-D-galactosamine by the enzyme present in the A' microsomes (Table IV) . It can be seen that only those oligosaccharides having the H determinant group acted as acceptors for the N-acetylgalactosaminyltransferase of the A' microsomes. The A7 microsomes failed to catalyze the transfer of this sugar to any of the oligosaccharides tested.
Conversion of A-mucin to A' mucin. Intestinal mucins isolated from A' and A-rats were examined as acceptors for the microsomal N-acetylgalactosaminyltransferase. As shown in Table V , both A' and A-mucins acted as acceptors for the A' microsomal enzyme. The A-mucin, however, was 5 times better as an acceptor than the A' one. No radioactivity was incorporated into either mucin using the A-microsomes. In addition, heat-treated A-microsomes acted as better acceptors than A' microsomes.
To establish that the N-acetyl-D-galactosamine, incorporated into the A-mucin by the enzyme in the A' microsomes, was forming the A blood group determinant, the mucin produced in the reaction was tested for A antigenic activity. Table VI shows the results of a hemagglutination inhibition study. The mixture containing the A-mucin acceptor was 4 times more effective in inhibiting human A-anti A hemagglutination than were the controls.
To further substantiate that A-mucin having no blood group A activity could be converted to a mucin with an A antigenic determinant by the enzyme in the A' microsomes, the product of the reaction was titrated with rabbit antihuman A precipitating antiserum. The results, described in Fig. 5 , showed that radioactive A' mucin produced by the A' microsomal enzyme was precipitated by the rabbit antiserum. 30% of the radioactive product was precipitated. The addition of an oligosaccharide having blood group A activity isolated from A' PSM inhibited visual precipitation of this product by the rabbit antiserum. The precipitation of radioactivity by the antiserum was also inhibited by this oligosaccharide (Table VII) . DISCUSSION The results show that red cells in all of the rats examined contained human blood group A and B antigens. All the rats were able to produce intestinal mucins having B and H antigenic activity, but 57% failed to synthesize mucins with blood group A activity. The mucins isolated from A+ rats appeared to have the same antigenic structure as human blood group A substance, since they inhibited human blood group A-anti A hemagglutination, and upon immunodiffusion examination, produced a precipitin line, which fused with the human group A salivary and intestinal mucins. Furthermore this immunoprecipitin line was abolished when the antisera to human blood group A substance were pretreated with human A secretor saliva, or with A' PSM. Since rats with A antigen on their red cells did not necessarily have A antigen in intestinal mucin, it appears that the antigenicity of the intestinal mucin need not always correspond to that of the red blood cell. This suggests that a system analogous to the secretornonsecretor relationship found in man (23) may exist in rats with respect to the secretion of A antigen in the intestine. In contrast to the described variation within rat mucins, studies using indirect immunofluorescent techniques showed an antigen cross-reacting with human blood group A substance in the glandular cells of the colon in all of the rats and monkeys examined (18) . Some aqueous extracts of submaxillary glands or gastric mucosa from pigs inhibited human blood group A-anti A hemagglutination, while some did not (19) (20) (21) , an observation similar to that in the present study. However, serological cross-reactivity of the red cells of these species with those of man was not examined in any of these studies. Existence of a species-specific complex blood group unique in each mammalian species has been amply documented (37) (38) (39) . However, the presence of antigens similar in structure to human AB antigens on the red cells of rats has not been reported.
In man, the inability to synthesize and to create ABH blood group substances in glandular tissues is probably due to the absence of a fucosyltransferase which is thought to be regulated by the secretor gene in the tissue (40, 41) . The absence of this enzyme, however, does not appear to explain the difference be- tween A' and A-rats, since this enzyme was active in the intestinal mucosa of all rats tested. Therefore, the possible absence of other glycosyltransferases required for mucin biosynthesis in the small intestinal mucosa was examined. Comparison of four glycosyltransferases in the intestines of A' and A-rats showed that the activities of these enzymes were the same in both groups. The enzymes examined were a polypeptidyl:Nacetylgalactosaminyltransferase, an N-acetylglucosaminyltransferase, a galactosyltransferase, and a fucosyltransferase. A fifth enzyme studied, i.e., an -N-acetylgalactosaminyltransferase, was found to be present only in A' rats. The specificity of the enzyme was examined using various acceptors, including human milk oligosaccharides of defined structure. The results of this study indicated that this enzyme catalyzes the addition of N-acetyl-D-galactosamine only to those acceptors having the H blood group determinant structure. The specificity of this enzyme, as found in rats, appears to be the same as that reported for the human enzyme (40, 42) . If the only difference between A' and A-rats is due to the apparent absence of the N-acetylgalactosaminyltransferase, A-mucin should be converted to A' mucin by this enzyme. In support of this hypothesis, incubation of A-mucin and UDP-N-acetyl-D-galactosamine with microsomes prepared from the intestinal mucosa of A' rats resulted in a product which inhibited human A-anti A hemagglutinations. This product was also precipitated with rabbit antisera against human group A red cell stroma. This precipitation was prevented by the presence of an oligosaccharide having human blood group A activity.
The H structure has been shown to be a precursor for the A determinant in man (42, 43) . The H activity of mucin was higher in the A-than in the A+ rat. Thus it appeared that while the A-mucin had the potential to acquire blood group A activity, the enzyme required for the final step in its synthesis, N-acetylgalactosaminyltransferase, was lacking or inactive in the A-rat. Although the quantities of the purified mucins available were too limited to allow a chemical comparison, the content of D-galactosamine bound to substances (presumably mucins) in the A+ microsomes was considerably higher than in A-microsomes, an observation consistent with the above concept. Based on the information obtained in this study, as well as those of a previous investigation of rat intestinal mucins (24), the structure shown in Fig. 4 has been proposed for the oligosaccharide side chains of A+ and Amucins.
The mechanism determining the synthesis of either A+ or A-mucins in rats appears to be based on a system similar to, but not identical with, that found in the human secretor-nonsecretor relationship. In the case of the human nonsecretor system, N-acetylgalactosaminyltransferase, required for the formation of the blood group A determinant, is present in the glandular tissues but this tissue is unable to form an acceptor for this enzyme, i.e., H substance. This inability stems from the lack of an a(1I ->2) fucosyltransferase, an enzyme essential for the completion of the H determinant structure (40, 41) . In contrast, all rats produce a mucin which has the precursor H structure. The "nonsecretor" rat, however, lacks the enzyme necessary for the completion of a mucin containing the A blood group determinant in glandular tissue.
Microheterogeneity of the oligosaccharide side chains of glycoproteins and mucins is well known and is thought to be due to varying degrees of completion of the oligosaccharide side chains (44, 45) . The observation that A' mucins had slight H activity and had about 20% of the acceptor ability of A-mucins may be a reflection of the microheterogeneity of the rat mucin oligosaccharides.
It has been shown that ABO blood group and secretor status are determined by separate gene that are responsible for the synthesis of oligosaccharide side chains with specific terminal sequences and linkages (25, 39, 40, 41) . Unlike the synthesis of proteins, the assembly of carbohydrate groups on glycoproteins is not under direct genetic control. The sequence of sugars in the oligosaccharide chain depends on the presence of different glycosyltransferases which catalyze the addition of specific sugars (46) ; the presence or absence of these enzymes furnishes the basis of genetic regulation. Whether mucins isolated from A' or Arats have different biological activities or different susceptibilities to degradation awaits clarification. Possible differences between these two groups of rats in susceptibility to 
